Dual effect of thymosin α 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonists

Expert Opinion on Biological Therapy

Volumn 15, Issue , 2015, Pages 59-70

  Giacomini, Elena ^a   Severa, Martina ^a   Cruciani, Melania ^a   Etna, Marilena Paola ^a   Rizzo, Fabiana ^a   Pardini, Manuela ^a   Scagnolari, Carolina ^a,b   Garaci, Enrico ^c   Coccia, Eliana Marina ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Dendritic cell; Human; Thymosin 1; Toll like receptor

Indexed keywords

HLA A1 ANTIGEN; HLA A2 ANTIGEN; INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; THYMOSIN ALPHA1; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR; CYTOKINE; THYMOSIN; TOLL LIKE RECEPTOR;

ARTICLE; CELL MATURATION; CELL STIMULATION; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNE RESPONSE; IN VITRO STUDY; MONOCYTE; MYCOBACTERIUM BOVIS BCG; AGONISTS; ANALOGS AND DERIVATIVES; CELL CULTURE; DRUG EFFECTS; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); MICROBIOLOGY; MYCOBACTERIUM BOVIS; T LYMPHOCYTE;

CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MONOCYTES; MYCOBACTERIUM BOVIS; T-LYMPHOCYTES; THYMOSIN; TOLL-LIKE RECEPTORS;

EID: 84957789576     PISSN: 14712598     EISSN: 17447682     Source Type: Journal    
DOI: 10.1517/14712598.2015.1019460     Document Type: Article

References (41)

1. Goldstein AL, Guha A, Zatz MM, et al. Purification and biological activity of thymosin, a hormone of the thymus gland. Proc Natl Acad Sci USA 1972;69(7):1800-3
2. Billich A. Thymosin alpha1. SciClone Pharmaceuticals. Curr Opin Investig Drugs 2002;3(5):698-707
3. Loggi E, Gramenzi A, Margotti M, et al. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. J Viral Hepat 2008;15(6):442-8
4. Grandini E, Cannoletta F, Scuteri A, et al. Immunological modifications during treatment with thymosin alpha1 plus antiviral therapy in chronic hepatitis C. Ann N Y Acad Sci 2010;1194:147-52
5. Chadwick D, Pido-Lopez J, Pires A, et al. A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy. Clin Exp Immunol 2003;134(3):477-81
6. Perruccio K, Bonifazi P, Topini F, et al. Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation. Ann N Y Acad Sci 2010;1194:153-61
7. Garaci E, Pica F, Sinibaldi-Vallebona P, et al. Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer. Int Immunopharmacol 2003;3(8):1145-50
8. Lopez M, Carpano S, Cavaliere R, et al. Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects. Ann Oncol 1994;5(8):741-6
9. Romani L, Bistoni F, Montagnoli C, et al. Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance. Ann N Y Acad Sci 2007;1112:326-38
10. Pierluigi B, D’Angelo C, Fallarino F, et al. Thymosin alpha1: the regulator of regulators? Ann N Y Acad Sci 2010;1194:1-5
11. Gao X, Bai H, Cheng J, et al. CD8alpha+ and CD8alpha- DC subsets from BCG-infected mice inhibit allergic Th2-cell responses by enhancing Th1-cell and Treg-cell activity respectively. Eur J Immunol 2012;42(1):165-75
12. Yao Q, Doan LX, Zhang R, et al. Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes. Immunol Lett 2007;110(2):110-20
13. Romani L, Bistoni F, Gaziano R, et al. Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood 2004;103(11):4232-9
14. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392(6673):245-52
15. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34(5):637-50
16. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81(1):1-5
17. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008;8(4):279-89
18. Barton GM, Kagan JC. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol 2009;9(8):535-42
19. Zhang P, Chan J, Dragoi AM, et al. Activation of IKK by thymosin alpha1 requires the TRAF6 signalling pathway. EMBO Rep 2005;6(6):531-7
20. Bozza S, Gaziano R, Bonifazi P, et al. Thymosin alpha1 activates the TLR9/ MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo. Int Immunol 2007;19(11):1261-70
21. Etna MP, Giacomini E, Severa M, et al. A human dendritic cell-based in vitro model to assess Mycobacterium tuberculosis SO2 vaccine immunogenicity. ALTEX 2014;31(4):397-406
22. Tuthill C, Rios I, De Rosa A, Camerini R. Thymosin alpha1 continues to show promise as an enhancer for vaccine response. Ann N Y Acad Sci 2012;1270:21-7
23. Ershler WB, Gravenstein S, Geloo ZS. Thymosin alpha 1 as an adjunct to influenza vaccination in the elderly: rationale and trial summaries. Ann N Y Acad Sci 2007;1112:375-84
24. Giacomini E, Iona E, Ferroni L, et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001;166(12):7033-41
25. Giacomini E, Sotolongo A, Iona E, et al. Infection of human dendritic cells with a Mycobacterium tuberculosis sigE mutant stimulates production of high levels of interleukin-10 but low levels of CXCL10: impact on the T-cell response. Infect Immun 2006;74(6):3296-304
26. Scagnolari C, Trombetti S, Solda A, et al. Pandemic 2009 H1N1 influenza virus is resistant to the antiviral activity of several interferon alpha subtypes. J Interferon Cytokine Res 2011;31(6):475-9
27. Coccia EM, Severa M, Giacomini E, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004;34(3):796-805
28. Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet 2010;375(9731):2110-19
29. Osterlund P, Pirhonen J, Ikonen N, et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 2010;84(3):1414-22
30. Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 2010;33(4):492-503
31. Romani L, Moretti S, Fallarino F, et al. Jack of all trades: thymosin alpha1 and its pleiotropy. Ann N Y Acad Sci 2012;1269:1-6
32. Chretien PB, Lipson SD, Makuch R, et al. Thymosin in cancer patients: in vitro effects and correlations with clinical response to thymosin immunotherapy. Cancer Treat Rep 1978;62(11):1787-90
33. Schulof RS, Lloyd MJ, Cleary PA, et al. A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer. J Biol Response Mod 1985;4(2):147-58
34. Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 2004;4(11):841-55
35. Romani L, Bistoni F, Perruccio K, et al. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 2006;108(7):2265-74
36. Payen D, Monneret G, Hotchkiss R. Immunotherapy - a potential new way forward in the treatment of sepsis. Crit Care 2013;17(1):118
37. Huang Y, Chen Z, Zhou C, et al. The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-alpha. Int Immunopharmacol 2004;4(4):539-46
38. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711
39. Segura E, Touzot M, Bohineust A, et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013;38(2):336-48
40. Anonymous. Global tuberculosis control 2008: surveillance, planning, financing. WHO report 2008
41. Liu J, Tran V, Leung AS, et al. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccin 2009;5(2):70-8